Pharma Giant Novo Nordisk Discloses Breach of Clinical Trials Data

Novo Nordisk disclosed a security incident impacting clinical trial participant data, potentially exposing highly sensitive medical and genetic information; the company is investigating scope and compliance obligations under GDPR and other clinical-data regulations while details such as the number of affected participants and attack vector remain unknown.